Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06186648
Status:
RECRUITING
Last Update Posted:
2024-04-19
First Post:
2023-12-06
Brief Title:
Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome
Sponsor:
Organization:
French Innovative Leukemia Organisation